Connect with us

Noosa News

Experts hail addition of two more vaccines to nation’s virus portfolio

Published

on

Rather, Dr Griffin said, it boosted Australia’s “vaccine portfolio”.

“This gives us additional options and given they’re slightly different technologies they’re very complimentary to the two vaccines we already have an agreement for,” he said.

The vaccine candidates secured by Australia

Newly announced:

  • Novavax- 40 million doses – currently in stage 2 and 3 clinical trials
  • Pfizer- 10 million doses – currently in stage 2 and 3 clinical trials

Previously announced:

  • UQ/CSL – 51 million doses – currently in an expanded stage 1 clinical trial
  • University of Oxford/ AstraZeneca – 33.8 million doses – currently in stage 2 and 3 clinical trials

“Having an arrangement now for four vaccines gives us a better chance of having a vaccine…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending